<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01264562</url>
  </required_header>
  <id_info>
    <org_study_id>DKH 109132</org_study_id>
    <nct_id>NCT01264562</nct_id>
  </id_info>
  <brief_title>Cognition in Breast Cancer Patients: The Impact of Cancer-related Stress</brief_title>
  <acronym>Cognicares</acronym>
  <official_title>Cognition in Breast Cancer Patients: The Impact of Cancer-related Stress</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Deutsche Krebshilfe e.V., Bonn (Germany)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will investigate the impact of cancer-related stress and its consequences (acute
      and posttraumatic stress symptoms, altered cortisol secretion) on cognitive function in
      breast cancer patients. The hypothesis that stress associated with the cancer diagnosis and
      the cancer treatment is a major cause of cognitive dysfunction in breast cancer patients
      shall be evaluated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary hypothesis:

      *The adverse effects of cancer and cancer therapy on cognitive function in breast cancer
      patients are entirely or partly mediated by stress and the ensuing dysfunction of the
      HPA-axis.

      Secondary objectives:

        -  Determining the effect of cancer diagnosis, chemotherapy, disease-related stress, acute
           stress response, posttraumatic stress disorder, posttraumatic stress symptoms, anxiety,
           and depression on the HPA-axis in breast cancer patients

        -  Determining the effect of cognitive dysfunction assessed with neuropsychological tests,
           cancer diagnosis, chemotherapy, disease-related stress, acute stress response,
           posttraumatic stress disorder, posttraumatic stress symptoms, anxiety, and depression on
           subjective cognitive function in breast cancer patients

        -  Prevalence of acute stress response, posttraumatic stress disorder and posttraumatic
           stress symptoms, and extent of cancer-specific stress in breast cancer patients treated
           with or without chemotherapy
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Course of cognitive function</measure>
    <time_frame>12 months</time_frame>
    <description>Performance on a battery of cognitive tests</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Course of subjective cognitive function</measure>
    <time_frame>12 months</time_frame>
    <description>Self-reported cognitive problems</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Course of the HPA-axis function</measure>
    <time_frame>12 months</time_frame>
    <description>Cortisol awakening response and diurnal profile</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Course of the stress response</measure>
    <time_frame>12 months</time_frame>
    <description>Acute stress response, posttraumatic stress disorder, and posttraumatic stress symptoms; cancer-specific stress</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">254</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Chemotherapy group</arm_group_label>
    <description>Breast cancer patients treated with chemotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-chemotherapy group</arm_group_label>
    <description>Breast cancer patients not treated with chemotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls</arm_group_label>
    <description>Women without a cancer diagnosis, matched for age and education</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients of the Ludwig Maximilian University of Munich Breast Cancer Center; Klinikum
        Landshut Department of Obstetrics and Gynecology and Breast Cancer Services; Kreisklinik
        Ebersberg Department of Gynecology and Obstetrics; Klinikum Dritter Orden Department of
        Gynecology and Obstetrics; Rotkreuzklinikum Muenchen Department of Gynecology and
        Obstetrics, Helios Amper Hospital Dachau, Department of Gynecology and Obstetrics
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria, both patient groups:

          -  primary breast cancer, stage 0-IIIc, therapy not yet started

          -  informed consent

        Inclusion Criteria, healthy control group:

          -  breast diagnostics with benign result (no treatment necessary)

          -  informed consent

        Exclusion Criteria:

          -  not fluent in German

          -  substance abuse

          -  history of psychosis

          -  history of neurologic disorder

          -  previous systemic cancer treatment

          -  Addison' disease

          -  Cushing's syndrome
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kerstin Hermelink, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ludwig Maximilian University, Department of Gynecology and Obstetrics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Frauenklinik des Helios Amper Klinikums Dachau</name>
      <address>
        <city>Dachau</city>
        <state>Bavaria</state>
        <zip>85221</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreisklinik Ebersberg</name>
      <address>
        <city>Ebersberg</city>
        <state>Bavaria</state>
        <zip>85560</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Landshut, Department of Obstetrics and Gynecology and Breast Cancer Services</name>
      <address>
        <city>Landshut</city>
        <state>Bavaria</state>
        <zip>84034</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rotkreuzklinikum Muenchen</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>80634</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dritter Orden</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>80638</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ludwig Maximilian University, Department of Gynecology and Obstetrics</name>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.klinikum.uni-muenchen.de/Brustzentrum/de/psychoonko/psy_grh/index.html</url>
    <description>website of the Ludwig Maximilian University of Munich, Breast Cancer Center, Psycho-Oncology</description>
  </link>
  <reference>
    <citation>Hermelink K, Bühner M, Harbeck N. Response. J Natl Cancer Inst. 2016 Apr 13;108(8). pii: djw049. doi: 10.1093/jnci/djw049. Print 2016 Aug.</citation>
    <PMID>27075856</PMID>
  </reference>
  <results_reference>
    <citation>Hermelink K, Voigt V, Kaste J, Neufeld F, Wuerstlein R, Bühner M, Münzel K, Rjosk-Dendorfer D, Grandl S, Braun M, von Koch FE, Härtl K, Hasmüller S, Bauerfeind I, Debus G, Herschbach P, Harbeck N. Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress. J Natl Cancer Inst. 2015 Apr 16;107(7). pii: djv099. doi: 10.1093/jnci/djv099. Print 2015 Jul.</citation>
    <PMID>25882713</PMID>
  </results_reference>
  <results_reference>
    <citation>Voigt V, Neufeld F, Kaste J, Bühner M, Sckopke P, Wuerstlein R, Hellerhoff K, Sztrókay-Gaul A, Braun M, von Koch FE, Silva-Zürcher E, Hasmüller S, Bauerfeind I, Debus G, Herschbach P, Mahner S, Harbeck N, Hermelink K. Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study. Psychooncology. 2017 Jan;26(1):74-80. doi: 10.1002/pon.4102. Epub 2016 Feb 22.</citation>
    <PMID>26898732</PMID>
  </results_reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 20, 2010</study_first_submitted>
  <study_first_submitted_qc>December 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2010</study_first_posted>
  <last_update_submitted>May 1, 2016</last_update_submitted>
  <last_update_submitted_qc>May 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Kerstin Hermelink</investigator_full_name>
    <investigator_title>Study Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>chemotherapy, adjuvant</keyword>
  <keyword>adverse effects</keyword>
  <keyword>breast neoplasms</keyword>
  <keyword>cognition disorders</keyword>
  <keyword>Stress Disorders, post-traumatic</keyword>
  <keyword>cortisol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

